Navigation Links
Statement by Robert D. Foreman, President of The Kidney Care Council, Regarding the HHS Report to Congress 'A Design for a Bundled End Stage Renal Disease Prospective Payment System'
Date:2/21/2008

WASHINGTON, Feb. 21 /PRNewswire-USNewswire/ -- The following is a statement by Robert D. Foreman, President of The Kidney Care Council:

"The Kidney Care Council (KCC) supports the findings of the Centers for Medicare & Medicaid Services (CMS) which in a long awaited report yesterday made clear that the time for a modernized and fully bundled case-mix adjusted prospective payment system for dialysis services is upon us. We could not agree more.

"For too long, the dialysis payment system has languished far behind other prospective payment systems in Medicare and has suffered from a lack of an annual updating mechanism. We are pleased to see the report recognizes the under-funding of the composite payment rate which cites the average cost of a treatment was $162.00 versus a reimbursement of $143.20.

"The report leaves open some details about the bundle's basic design features that need to be resolved for a new payment system to be fully successful. Specifically, the success of the revised payment mechanism will depend largely on the establishment of an appropriate rate at the outset as well as the design of an annual update mechanism. However, we are pleased by the progress and insights in the report and are eager to work collaboratively with CMS and with Congress this year.

"The KCC also applauds the work of those in the Government Accountability Office, the Medicare Payment Advisory Commission, and in Congress in advancing the payment modernization cause. The CMS report is a fitting culmination to more than a decade of thoughtful work by CMS and leading researchers on how best to reimburse care for Medicare's most vulnerable beneficiaries. Congress now has before it a concrete and detailed proposal. Now, let the hard work of making it happen begin.

"The KCC has endorsed payment reform and has taken a collaborative approach to positive change for the dialysis payment system, working closely with Congress, CMS, and patient and stakeholder groups to secure a system that maximizes taxpayer value and promotes high quality care. We believe the expanded prospective payment envisioned in this report will provide stable, predictable reimbursement that will support continued improvement in clinical patient outcomes. To these ends, the KCC will continue working with Members of Congress to enact these long overdue changes this year.

The Kidney Care Council (KCC) is a nonprofit Washington-based health care trade association of eleven renal care companies that collectively provide End-Stage Renal Disease (ESRD) services to nearly 80 percent of the dialysis patients in the United States. The membership includes large, small, nonprofit and for-profit provider companies. The KCC's mission is to improve patient care through demonstrable improvements in patient outcomes, patient safety, and quality of life measures. The KCC is dedicated to improving quality as well as promoting education so that newly diagnosed patients fully understand this disease and how to slow its progression and reduce complications.


'/>"/>
SOURCE Kidney Care Council (KCC)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide
2. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
3. AHIP Statement on New York Attorney Generals Announcement
4. NCPA Statement on Economic Stimulus Package
5. Blue Cross of California Statement
6. Statement by James P. Firman, Chair Leadership Council of Aging Organizations (LCAO) on the Presidents FY2009 Budget Proposal
7. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
8. NCPA Statement in Response to President Bushs FY 2009 Budget Proposal
9. NCPA Statement on White House Campaign to End Teenage Prescription Drug Abuse
10. Statement of the American Diabetes Association on the Administrations Proposal to Undermine Funds for Research, Prevention and Treatment in FY09
11. NutraCea Files Universal Shelf Registration Statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... , ... Dr. Rassouli, cosmetic dentist in Orange County , is now ... cosmetic procedures in dentistry today, but the cost often leads to patients looking to ... teeth whitening-related damage. For a limited time, Dr. Rassouli is offering this special whitening ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... “Ebola: In Praise of Prevention,” an animated video designed to prevent ... French translations of the video are being distributed throughout Togo, Liberia, Sierra Leone, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... CURE Media ... has officially launched the Multiple Myeloma Heroes Awards event , which will annually ... the lives of patients with MM. The MM Heroes Awards nomination process ...
(Date:2/8/2016)... ... ... famous for gift giving with flowers, chocolates and other tokens of affection meant to remind ... than 5.6 million Americans suffering with Alzheimer’s, those store bought gifts - no matter ... they’ve led and the people they’ve touched. , That’s why Give To ...
(Date:2/8/2016)... SC (PRWEB) , ... February 08, 2016 , ... Steve ... areas with a vital new community enrichment program, has teamed up with Citizens Opposed ... and children suffering from intimate abuse. To support all those victimized by the fear ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb.8, 2016 Aesthetic Devices - Medical ... Devices sector report, "Aesthetic Devices - Medical Devices Pipeline ... in pipeline stage. This report is ... primary research by GlobalData,s team of industry experts. ... or altered based on the availability and relevance of ...
(Date:2/8/2016)... N.J. , Feb. 8, 2016  Otsuka Pharmaceutical ... announced that they have entered into a licensing agreement ... in the U.S. and Puerto Rico ... a topical, non-steroidal phosphodiesterase IV (PDE-4) inhibitor, a new ... --> In a Phase II clinical ...
(Date:2/8/2016)... 2016  Echo Therapeutics, Inc. (Nasdaq: ... on non-invasive continuous glucose monitoring (CGM) and ... it will host a webcast and conference ... 9:00 a.m. Eastern Time to provide a ... advancements in its CGM system, and its ...
Breaking Medicine Technology: